Data as of Aug 29
| +0.52 / +1.69%|
The 2 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 46.50, with a high estimate of 55.00 and a low estimate of 38.00. The median estimate represents a +48.66% increase from the last price of 31.28.
The current consensus among 2 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.